These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8203552)

  • 1. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition.
    Fujihara CK; Michellazzo SM; de Nucci G; Zatz R
    Am J Physiol; 1994 May; 266(5 Pt 2):F697-705. PubMed ID: 8203552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy.
    Fujihara CK; De Nucci G; Zatz R
    J Am Soc Nephrol; 1995 Jan; 5(7):1498-507. PubMed ID: 7535572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade.
    Yamada SS; Sassaki AL; Fujihara CK; Malheiros DM; De Nucci G; Zatz R
    Hypertension; 1996 May; 27(5):1165-72. PubMed ID: 8621212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury.
    Fujihara CK; Sena CR; Malheiros DM; Mattar AL; Zatz R
    Am J Physiol Renal Physiol; 2006 Mar; 290(3):F632-40. PubMed ID: 16204410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition.
    Ribeiro MO; Antunes E; Muscará MN; De Nucci G; Zatz R
    Hypertension; 1995 Jul; 26(1):150-5. PubMed ID: 7541779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycorticosterone suppresses the effects of losartan in nitric oxide-deficient hypertensive rats.
    DE Gracia MC; Osuna A; O'Valle F; Del Moral RG; Wangensteen R; Del Rio CG; Vargas F
    J Am Soc Nephrol; 2000 Nov; 11(11):1995-2000. PubMed ID: 11053474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic role of innate immunity in a model of chronic NO inhibition associated with salt overload.
    Zambom FFF; Oliveira KC; Foresto-Neto O; Faustino VD; Ávila VF; Albino AH; Arias SCA; Volpini RA; Malheiros DMAC; Saraiva Camara NO; Zatz R; Fujihara CK
    Am J Physiol Renal Physiol; 2019 Oct; 317(4):F1058-F1067. PubMed ID: 31411073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do ETA receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade?
    Fujihara CK; De Nucci G; Zatz R
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S462-5. PubMed ID: 8587446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition.
    Mattar AL; Machado FG; Fujihara CK; Malheiros DM; Zatz R
    Clinics (Sao Paulo); 2007 Dec; 62(6):749-56. PubMed ID: 18209918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.
    Polichnowski AJ; Licea-Vargas H; Picken M; Long J; Bisla R; Williamson GA; Bidani AK; Griffin KA
    Am J Physiol Renal Physiol; 2015 Nov; 309(9):F791-9. PubMed ID: 26109088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
    Ribeiro MO; Antunes E; de Nucci G; Lovisolo SM; Zatz R
    Hypertension; 1992 Sep; 20(3):298-303. PubMed ID: 1516948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-κB blockade during short-term l-NAME and salt overload strongly attenuates the late development of chronic kidney disease.
    Oliveira KC; Zambom FFF; Albino AH; Alarcon Arias SC; Ávila VF; Faustino VD; Malheiros DMAC; Camara NOS; Fujihara CK; Zatz R
    Am J Physiol Renal Physiol; 2020 Aug; 319(2):F215-F228. PubMed ID: 32463727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of albuminuria in the chronic nitric oxide inhibition model.
    Arcos MI; Fujihara CK; Sesso A; de Almeida Prado EB; de Almeida Prado MJ; de Nucci G; Zatz R
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1060-6. PubMed ID: 11097624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation prevents intraglomerular platelet aggregation and glomerular injury induced by chronic inhibition of nitric oxide synthesis.
    Nakashima A; Matsuoka H; Yasukawa H; Kohno K; Nishida H; Nomura G; Imaizumi T; Morimatsu M
    Nephron; 1996; 73(1):34-40. PubMed ID: 8742954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
    François H; Placier S; Flamant M; Tharaux PL; Chansel D; Dussaule JC; Chatziantoniou C
    FASEB J; 2004 May; 18(7):926-8. PubMed ID: 15033924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal thrombotic microangiopathy in a genetic model of hypertension in mice.
    Sethi S; Iida S; Sigmund CD; Heistad DD
    Exp Biol Med (Maywood); 2006 Feb; 231(2):196-203. PubMed ID: 16446496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
    Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.
    Qiu C; Engels K; Baylis C
    Am J Physiol; 1994 May; 266(5 Pt 2):R1470-6. PubMed ID: 8203622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.
    Wangensteen R; O'Valle F; Del Moral R; Vargas F; Osuna A
    Med Sci Monit; 2002 Sep; 8(9):BR378-84. PubMed ID: 12221376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.